scholarly journals Artificial intelligence advanced imaging report standardization and intra-interdisciplinary clinical workflow

EBioMedicine ◽  
2019 ◽  
Vol 44 ◽  
pp. 4-5 ◽  
Author(s):  
Jie Tian
Author(s):  
Antonio Fusco ◽  
Grazia Dicuonzo ◽  
Vittorio Dell’Atti ◽  
Marco Tatullo

The SARS-CoV2 pandemic has impacted risk management globally. Blockchain has been increasingly applied to healthcare management, as a strategic tool to strengthen operative protocols and to create the proper basis for an efficient and effective evidence-based decisional process. We aim to validate blockchain in healthcare, and to suggest a trace-route for a COVID19-safe clinical practice. The use of blockchain in combination with artificial intelligence systems allows the creation of a generalizable predictive system that could contribute to the containment of pandemic risk on national territory. A SWOT analysis of the adoption of a blockchain-based prediction model in healthcare and SARS-CoV-2 infection has been carried out to underline opportunities and limits to its adoption. Blockchain could play a strategic role in future digital healthcare: specifically, it may work to improve COVID19-safe clinical practice. The main concepts, and particularly those related to clinical workflow, obtainable from different blockchain-based models have been reported here and critically discussed.


2019 ◽  
Vol 16 (9) ◽  
pp. 1318-1328 ◽  
Author(s):  
Zeynettin Akkus ◽  
Jason Cai ◽  
Arunnit Boonrod ◽  
Atefeh Zeinoddini ◽  
Alexander D. Weston ◽  
...  

2020 ◽  
Author(s):  
Behrooz Hashemian ◽  
Aman Manchanda ◽  
Matthew D. Li ◽  
Parisa Farzam ◽  
Suma D. Dash ◽  
...  

Abstract The global COVID-19 pandemic has disrupted patient care delivery in healthcare systems world-wide. For healthcare providers to better allocate their resources and improve the care for patients with severe disease, it is valuable to be able to identify those patients with COVID-19 who are at higher risk for clinical complications. This may help to optimize clinical workflow and more efficiently allocate scarce medical resources. To this end, medical imaging shows great potential and artificial intelligence (AI) algorithms have been developed to assist in diagnosing and risk stratifying COVID-19 patients. However, despite the rapid development of numerous AI models, these models cannot be clinically useful unless they can be deployed in real-world environments in real-time on clinical data. Here, we propose an end-to-end AI hospital-deployment architecture for COVID-19 medical imaging algorithms in hospitals. We have successfully implemented this system at our institution and it has been used in prospective clinical validation of a deep learning algorithm potentially useful for triaging of patients with COVID-19. We demonstrate that many orchestration processes are required before AI inference can be performed on a radiology studies in real-time with the AI model being just one of the components that make up the AI deployment system. We also highlight that failure of any one of these processes can adversely affect the model's performance.


Neurosurgery ◽  
2019 ◽  
Vol 87 (1) ◽  
pp. 33-44 ◽  
Author(s):  
Sandip S Panesar ◽  
Michel Kliot ◽  
Rob Parrish ◽  
Juan Fernandez-Miranda ◽  
Yvonne Cagle ◽  
...  

Abstract Artificial intelligence (AI)-facilitated clinical automation is expected to become increasingly prevalent in the near future. AI techniques may permit rapid and detailed analysis of the large quantities of clinical data generated in modern healthcare settings, at a level that is otherwise impossible by humans. Subsequently, AI may enhance clinical practice by pushing the limits of diagnostics, clinical decision making, and prognostication. Moreover, if combined with surgical robotics and other surgical adjuncts such as image guidance, AI may find its way into the operating room and permit more accurate interventions, with fewer errors. Despite the considerable hype surrounding the impending medical AI revolution, little has been written about potential downsides to increasing clinical automation. These may include both direct and indirect consequences. Directly, faulty, inadequately trained, or poorly understood algorithms may produce erroneous results, which may have wide-scale impact. Indirectly, increasing use of automation may exacerbate de-skilling of human physicians due to over-reliance, poor understanding, overconfidence, and lack of necessary vigilance of an automated clinical workflow. Many of these negative phenomena have already been witnessed in other industries that have already undergone, or are undergoing “automation revolutions,” namely commercial aviation and the automotive industry. This narrative review explores the potential benefits and consequences of the anticipated medical AI revolution from a neurosurgical perspective.


Diagnostics ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 959
Author(s):  
Jasper J. Twilt ◽  
Kicky G. van Leeuwen ◽  
Henkjan J. Huisman ◽  
Jurgen J. Fütterer ◽  
Maarten de Rooij

Due to the upfront role of magnetic resonance imaging (MRI) for prostate cancer (PCa) diagnosis, a multitude of artificial intelligence (AI) applications have been suggested to aid in the diagnosis and detection of PCa. In this review, we provide an overview of the current field, including studies between 2018 and February 2021, describing AI algorithms for (1) lesion classification and (2) lesion detection for PCa. Our evaluation of 59 included studies showed that most research has been conducted for the task of PCa lesion classification (66%) followed by PCa lesion detection (34%). Studies showed large heterogeneity in cohort sizes, ranging between 18 to 499 patients (median = 162) combined with different approaches for performance validation. Furthermore, 85% of the studies reported on the stand-alone diagnostic accuracy, whereas 15% demonstrated the impact of AI on diagnostic thinking efficacy, indicating limited proof for the clinical utility of PCa AI applications. In order to introduce AI within the clinical workflow of PCa assessment, robustness and generalizability of AI applications need to be further validated utilizing external validation and clinical workflow experiments.


Sign in / Sign up

Export Citation Format

Share Document